Radboud University Medical Center
Clinical trials sponsored by Radboud University Medical Center, explained in plain language.
-
Step by step: a coaching program aims to keep heart patients moving after rehab
Disease control Not yet recruitingThis trial tests whether a 9-month program called STEP COACH can help people with coronary artery disease stay physically active after completing cardiac rehab. Participants use their own smartwatch or smartphone to track steps and receive coaching on increasing both step volume …
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for advanced thyroid cancer: personalized drug cocktails tested
Disease control Not yet recruitingThis early-phase trial tests whether giving advanced thyroid cancer patients a personalized mix of already-approved drugs, chosen based on their tumor's genetic profile, is feasible and safe. Ten patients with no other treatment options will receive individualized drug combinatio…
Phase: PHASE1 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
MRI-guided radiation aims to slash side effects in endometrial cancer
Disease control Not yet recruitingThis study tests a new way to deliver radiotherapy for endometrial cancer after surgery. Using real-time MRI guidance, doctors can target radiation more accurately and reduce damage to nearby organs like the bowel and bladder. About 61 women will receive five high-dose sessions o…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Personalized vaccine aims to stop lynch syndrome cancers before they start
Prevention Not yet recruitingThis phase III trial tests whether a vaccine made from a person's own immune cells can prevent cancer in 372 adults with Lynch syndrome, a genetic condition that raises cancer risk. Participants receive either the vaccine or a placebo and are monitored for tumor development. The …
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Could a vaccine stop cancer before it starts in lynch syndrome?
Prevention Not yet recruitingThis early-phase trial tests a personalized vaccine made from a person's own immune cells (dendritic cells) loaded with cancer-specific markers. The goal is to train the immune system to recognize and destroy precancerous cells in people with Lynch syndrome, who have a high risk …
Phase: PHASE1, PHASE2 • Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Could a wakefulness drug beat fatigue in IBD patients?
Symptom relief Not yet recruitingThis study tests whether modafinil, a drug used for sleep disorders, can reduce severe fatigue in adults with inactive inflammatory bowel disease (IBD). Sixty participants will take either modafinil or a placebo for 8 weeks, starting at 100 mg daily with possible dose increases. …
Phase: PHASE2, PHASE3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Could a malaria drug ease lingering lyme symptoms?
Symptom relief Not yet recruitingThis study tests whether adding hydroxychloroquine (a malaria drug) to standard doxycycline treatment can reduce long-term complaints in adults with Lyme disease. Fifty participants will take either hydroxychloroquine or a placebo twice daily for 28 days, with follow-up visits ov…
Phase: PHASE4 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can a fully digital approach replace the wax bite in making night guards?
Knowledge-focused Not yet recruitingThis study tests whether occlusal splints (night guards) made using a fully digital workflow are as comfortable and effective as those made with a traditional wax bite registration. Healthy volunteers aged 18 to 45 will wear both types of splints overnight for three weeks each. T…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
700 men with prostate cancer to help shape future treatments
Knowledge-focused Not yet recruitingThis study will follow 700 men with high-risk localized or metastatic prostate cancer to collect detailed information on how they are treated in everyday practice. Researchers will track treatments, side effects, quality of life, and disease progression over time. The goal is to …
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New study aims to improve inhaler treatment for lung fungus
Knowledge-focused Not yet recruitingThis study looks at how well an inhaled antifungal drug (liposomal amphotericin B) reaches the lungs in people with chronic pulmonary aspergillosis, a long-term lung infection. About 18 adults will inhale two different doses on separate days and then have special scans to see whe…
Phase: PHASE1 • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Dutch researchers check if weight-loss drug lives up to hype in real-world clinics
Knowledge-focused Not yet recruitingThis study will look at medical records of 1700 adults with obesity who took tirzepatide along with lifestyle coaching at several Dutch clinics. Researchers want to see how much weight people actually lose after six months and how doctors prescribe the medication in daily practic…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New study explores digital tools to keep care going in crises
Knowledge-focused Not yet recruitingThis study looks at whether a hybrid care model—using telemonitoring, teleconsultations, and online tools—can help patients with type 2 diabetes or chronic heart failure get regular care during health emergencies like pandemics. Researchers will follow 180 patients for one year, …
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:29 UTC